Bolt Biotherapeutics, Inc. Diluted Shares Outstanding (Weighted Average)
Bolt Biotherapeutics, Inc. (BOLT) reported Diluted Shares Outstanding (Weighted Average) of 1.69 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-11
- Bolt Biotherapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 1.69M shares, a 11.84% decline year-over-year.
- Bolt Biotherapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 1.68M shares, a 12.34% decline year-over-year.
- Bolt Biotherapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 1.73M shares, a 9.85% decline year-over-year.
- Bolt Biotherapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 1.92M shares, a 0.36% increase year-over-year.
- Bolt Biotherapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 1.87M shares, a 2.06% decline from fiscal 2024.
- Bolt Biotherapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 1.91M shares, a 94.95% decline from fiscal 2023.
- Bolt Biotherapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 37.81M shares, a 1.21% increase from fiscal 2022.
- Bolt Biotherapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 37.36M shares, a 12.54% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.69M shares 10-Q · filed 2026-08-11 | 1.69M shares 10-Q · filed 2026-08-11 | 1.70M shares derived: average of 3 quarters · filed 2026-08-11 | 1.75M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | 1.68M shares 10-Q · filed 2026-05-12 | 1.70M shares derived: average of 2 quarters · filed 2026-05-12 | 1.78M shares derived: average of 3 quarters · filed 2026-05-12 | 1.81M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | 1.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 1.82M shares derived: average of 2 quarters · filed 2026-03-12 | 1.85M shares derived: average of 3 quarters · filed 2026-08-11 | 1.87M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 1.92M shares 10-Q · filed 2025-11-12 | 1.92M shares derived: average of 2 quarters · filed 2026-08-11 | 1.92M shares 10-Q · filed 2025-11-12 | 1.92M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | 1.92M shares 10-Q · filed 2026-08-11 | 1.92M shares 10-Q · filed 2026-08-11 | 1.92M shares derived: average of 3 quarters · filed 2026-08-11 | 1.92M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | 1.92M shares 10-Q · filed 2026-05-12 | 38.34M shares 10-Q · filed 2025-05-12 | 1.92M shares derived: average of 2 quarters · filed 2026-05-12 | 1.91M shares derived: average of 3 quarters · filed 2026-05-12 | 1.91M shares derived: average of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | 1.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 1.91M shares derived: average of 2 quarters · filed 2026-03-12 | 1.91M shares derived: average of 3 quarters · filed 2026-03-12 | 1.91M shares 10-K · filed 2026-03-12 | 38.18M shares 10-K · filed 2025-03-24 | |||
| 2024-09-30 | 1.91M shares 10-Q · filed 2025-11-12 | 38.25M shares 10-Q · filed 2024-11-12 | 1.91M shares derived: average of 2 quarters · filed 2025-11-12 | 1.91M shares 10-Q · filed 2025-11-12 | 38.15M shares 10-Q · filed 2024-11-12 | 19.96M shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 1.91M shares 10-Q · filed 2025-08-14 | 38.13M shares 10-Q · filed 2024-08-13 | 1.91M shares 10-Q · filed 2025-08-14 | 38.10M shares 10-Q · filed 2024-08-13 | 25.97M shares derived: average of 3 quarters · filed 2025-08-14 | 28.95M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 38.07M shares 10-Q · filed 2025-05-12 | 38.01M shares derived: average of 2 quarters · filed 2025-05-12 | 37.96M shares derived: average of 3 quarters · filed 2025-05-12 | 37.91M shares derived: average of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | 37.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 37.91M shares derived: average of 2 quarters · filed 2025-03-24 | 37.85M shares derived: average of 3 quarters · filed 2025-03-24 | 37.81M shares 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | 37.87M shares 10-Q · filed 2024-11-12 | 37.81M shares derived: average of 2 quarters · filed 2024-11-12 | 37.77M shares 10-Q · filed 2024-11-12 | 37.71M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 37.75M shares 10-Q · filed 2024-08-13 | 37.72M shares 10-Q · filed 2024-08-13 | 37.66M shares derived: average of 3 quarters · filed 2024-08-13 | 37.61M shares derived: average of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | 37.68M shares 10-Q · filed 2024-05-14 | 37.62M shares derived: average of 2 quarters · filed 2024-05-14 | 37.56M shares derived: average of 3 quarters · filed 2024-05-14 | 37.50M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | 37.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 37.50M shares derived: average of 2 quarters · filed 2024-03-21 | 37.43M shares derived: average of 3 quarters · filed 2024-03-21 | 37.36M shares 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | 37.45M shares 10-Q · filed 2023-11-09 | 37.37M shares derived: average of 2 quarters · filed 2023-11-09 | 37.29M shares 10-Q · filed 2023-11-09 | 37.30M shares derived: average of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | 37.29M shares 10-Q · filed 2023-08-07 | 37.21M shares 10-Q · filed 2023-08-07 | 37.25M shares derived: average of 3 quarters · filed 2023-08-07 | 37.24M shares derived: average of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | 37.13M shares 10-Q · filed 2023-05-11 | 37.22M shares derived: average of 2 quarters · filed 2023-05-11 | 37.22M shares derived: average of 3 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | 37.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | 37.26M shares derived: average of 2 quarters · filed 2023-03-29 | 33.20M shares 10-K · filed 2023-03-29 | |||||
| 2021-09-30 | 37.21M shares 10-Q · filed 2022-11-10 | 31.82M shares 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |